MapLight Therapeutics (MPLT) Liabilities and Shareholders Equity (2024 - 2026)
MapLight Therapeutics (MPLT) posted Liabilities and Shareholders Equity of $479.5 million for Q4 2025, up 86.42% sequentially from $257.2 million in Q3 2025, and up 250.22% YoY from $136.9 million in Q4 2024.
MapLight Therapeutics (MPLT) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends
MapLight Therapeutics has reported Liabilities and Shareholders Equity for 2 years, with the latest figure at $479.5 million in Q4 2025.
- Quarterly Liabilities and Shareholders Equity rose 250.22% year-over-year to $479.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $873.6 million (changed N/A YoY) and the FY2025 annual result came in at $479.5 million, up 250.22% from the prior year.
- Liabilities and Shareholders Equity rose to $479.5 million in Q4 2025 per MPLT's latest filing, from $257.2 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $479.5 million in Q4 2025 and troughed at $136.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | MapLight Therapeutics | 533.88 Mn | 533.88 Mn | - | 368.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 368.35 Mn |
| Dec 31, 2025 | 479.51 Mn |
| Sep 30, 2025 | 257.22 Mn |
| Dec 31, 2024 | 136.92 Mn |